Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Cannabis Compounds Prevented Covid Infection tbp ard003

<< Previous

Bullboard Posts

Next >>

Comment by NSX001on Jan 12, 2022 11:52am

134 Views

Post# 34308411

RE:RE:RE:Cannabis Compounds Prevented Covid Infection tbp ard003

Hey Villain, is that all you can say, it sounds like that's the extent of your vocabulary.
Most real investors here are researching and providing actual information that are found on actual sites. You just attack for the sake of attacking.

How about doing some research of your own instead of criticizing others postings. Your not really here to provide factual input are you?

I can be tolerent, but only to a degree, next attack on anyone here and it's off to the garbage bin for you.

NSX001

<< Previous

Bullboard Posts

Next >>

Two Canadian cannabis stocks just signed transformative agreements